Top Markets
Coin of the day
Dermisonics, Inc. Dermisonics, Inc.

Dermisonics, Inc.

DMSI
Rank in Stocks #42356
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment... Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.
Share Price
$0.00003
Last synced: 2026-08-11
Market Cap
$1.92K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Dermisonics, Inc. (DMSI)

Category

Operating Margin for Dermisonics, Inc. (DMSI)
Operating Margin as of 2026 TTM: 0.00%
According to Dermisonics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Dermisonics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.56% -
IE
0.00% -
CN
0.00% -
CH
0.00% -
CH
0.00% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.